Trial Profile
A study evaluating pharmacokinetics and pharmacodynamics of Anacetrapib in healthy young Japanese and white male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2017
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 12 Sep 2017 New trial record
- 08 Sep 2017 Results published in the Journal of Clinical Pharmacology